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Abstract 
Context: Although the number of studies on the economic impact of palliative care (PC) is 
growing, the great majority report costs from North America.  
Objectives: We aimed to provide a comprehensive overview of PC hospital cost components 
from the perspective of a European mixed funded health care system by identifying cost drivers 
of PC and quantifying their effect on hospital costs compared to usual care (UC). 
Methods: We performed a retrospective, observational analysis examining cost data from the 
last hospitalization of patients who died at a large academic hospital in Switzerland comparing 
patients receiving PC versus UC.  
Results: Total hospital costs were similar in PC and UC with a mean difference of CHF -2’777 
[95% confidence interval (CI) -12’713 to 8’506, p=0.60]. Average costs per day decreased by 
CHF -3’224 [95% CI -3’811 to -2’631, p<0.001] for PC patients with significant reduction of 
costs for diagnostic intervention and medication. Higher cost components for PC patients were 
catering, room, nursing, social counselling and non-medical therapists. In sensitivity analyses, 
when we restricted PC exposure to 3 days from admission, total costs and average costs per 
day were significantly lower for PC.  
Conclusion: Studies measuring the impact of PC on hospital costs should analyze various 
cost components beyond total costs in order to understand wanted and potentially unwanted 
cost-reducing effects. An international definition of a set of cost components, specific for cost-
impact PC studies, may help avoid superficial and potentially dangerous cost discussions.  
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Introduction 
Palliative Care (PC) improves the quality of care at the end of life, reduces symptoms and 
leads to a higher patient, family, and physician satisfaction when compared to curative 
treatments on regular wards.1-3  
The cost impact of PC has been explored in different contexts, but more often comparing 
hospital costs of PC vs. UC.3-18 The majority of these studies have focused on average daily 
costs and total costs (see appendix I).3-7,9,12-15 Other studies focus on direct costs that can be 
completely attributed to medications, procedures, or services such as patient care supplies 
and medication.3,4,11,12,15-18 Of these, the majority report lower costs for PC than for UC.3-7,9,11-
16,18 In addition, some of the studies analyze individual cost components such as pharmacy, 
laboratory, imaging or intensive care unit (ICU) costs.3,5,6,11,13,15,17 The majority of studies show 
a clear trend towards lower PC costs. Management, procedures or room costs are analyzed 
sporadically.5,15,17 A deeper analysis of cost components such as detailed staff or catering 
costs, have not been examined to date. Since staff costs account for about 64.5 % of Swiss 
hospital revenues, it is surprising that none of the aforementioned studies performed in other 
countries have focused on this cost type.19 
In addition, there is a lack of European research assessing the cost impact of PC, since most 
studies originate in the United States (US) and thus, concentrate on a privately funded 
healthcare system.3-11,13-18  Findings from the US cannot generally be transferred to a mixed 
private and socially funded health care system, as it exists in Switzerland and other countries.  
There are several reasons why the examination of PC from an economic perspective is crucial: 
One of the main global challenges in the next years is to keep fundable healthcare systems.2 
As an example, Swiss healthcare expenditures have been rising every year since 1990 by 
about 2%. The relative share of healthcare expenditures on the Gross Domestic Product was 
8% in 2010, whereas it grew to 12.1% in 2015.20 Additionally, Switzerland has a short history 
of encouraging PC. While in the US 60% of the hospitals report the existence of a PC program, 
in Switzerland 7.8% of stationary institutions run a certified PC program.13,20-22 Finally, 
according to the Swiss Federal Statistical Office, in 2015 the proportion of the population aged 
65 years and older was 18% and it is estimated that this share will increase to 26.4% in 2045.24 
Consequently, as the population ages and their needs become more complex, the greater 
need for PC will be inevitable.25  
In this study, we aimed to retrospectively analyze the cost impact of in-hospital PC with a 
particular focus on exploring which specific cost components drive the cost of PC. The majority 
of existing PC cost studies focus only on individual cost components. Therefore, this is the first 
study that gives a comprehensive overview of all occurred direct and indirect hospital costs. 
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Methods 
Study Design 
After receiving ethical approval (KEK-2017-00400), we performed a retrospective, 
observational cost analysis examining administrative and medical patient data from a large 
academic University hospital in Switzerland.  
Sample Selection 
We captured data from the last hospital admission of patients who died between January 1st 
and December 31st, 2015. Patients with dissent to further use of medical data 
(Humanforschungsgesetz – HFG) were excluded, as were perinatal deaths, deceased children 
(patients younger than 18 years of age), and patients who, according to the ICD-10, died due 
to an external cause, such as an accident or an injury. These deletions reduced the number 
from 976 to 780 cases. Lastly, after exclusion of ambulatory patients and patients with missing 
cost data, the final sample size included 746 patients (see Figure 1). All included patients were 
observed once.  
We classified patients as receiving PC if their time in PC accounted for more than 25% of the 
last stay and they had either: a) inpatient care at the PC ward; or b) if the patient was seen 
and evaluated by the PC team after a PC consultation was requested by the attending 
physician, or c) if the treating team received recommendations from the PC team. All other 
patients were classified as UC, including those who had PC input for less than 25% of the last 
hospitalization. Primarily, our rationale for the 25% criteria was because in Switzerland 
referrals to PC occur rather late in the care trajectory, including during the last hospitalization. 
Therefore, in order to include late referrals that may still have obtained a meaningful 
contribution from  during the last hospitalization, we chose 25% of PC involvement as the 
minimum. In the end, we included 642 patients in UC and 104 in PC.  
Clinical and Financial Data 
To gain a comprehensive financial overview of hospital costs, we required clinical and financial 
data from several sources (see Table 1 for an overview of all hospital databases employed). 
We derived clinical data from the patient characteristics’ database, which provides 
administrative information about, age, sex, death date, residency and marital status, as well 
as medical data such as main diagnoses, main treatments, Casemix-Index and cost weight. 
The cost weight is an empirically determined relative weight describing the average treatment 
effort of a given group of patients.26 The patient process database contains all in-house 
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movements of each patient, for instance patient movement from the emergency room (ER) to 
gastroenterology.  
From the hospital’s cost accounting system, we retrieved patient costs for each hospital day 
and for the entire admission period. The activity records database gives information about all 
services and items rendered including, staff activities, materials, laboratory and catering at the 
exact date and time when each activity occurred.  
We retrieved the sum of the costs for each patient from the cost unit accounting database. This 
database provides information about the costs per case and unit. For example, a patient 
generates an expense of CHF 2’500 in the surgery room. However, it does not have exact 
information on the corresponding date nor differentiates between performances given over a 
period of more than one day. For PC patients, costs arising before the PC intervention were 
not differentiated. 
As the activity records database does not include a detailed list of delivered medication, we 
gathered data from all in-house medication databases, namely the databases of the regular 
ward, the ER, and of the ICU.  
Development of Cost Matrix 
Accessing and merging the seven different databases was necessary to obtain the required 
level of detail, and which allowed for a comprehensive overview of all direct and indirect 
hospital costs. While direct costs can be completely attributed to medications, procedures, or 
services, indirect costs are not directly related to any specific service and involve different 
departments. In terms of hospital care, direct costs include, inter alia, patient care supplies, 
medication, imaging, pharmacy as well as room and board costs. Hospital overhead costs, 
such as general hospital administration, cleaning or facility services as well as information 
technology, are more difficult to assign to a patient and, therefore, are considered to be indirect 
or shared costs.27-29 
In order to capture all relevant hospital costs, we thoroughly reviewed the existing literature 
(see Table 2 for an overview of all cost components used to date to explore cost differences 
between UC and PC and refer to Appendix I for a more detailed summary). Since the different 
cost components belong to different categories, we assigned the costs components to three 
different categories: total costs, cost types, and organizational units. The category “total costs” 
labels all cost components that describe total costs in general. The second group describes 
where certain costs arise, and thus, include organizational units of a hospital such as ICU and 
imaging. The category “cost types” summarizes the different kinds of costs. 
We then matched the available hospital data with the already existing cost components from 
the literature. In order to get a comprehensive overview of all incurred hospital costs, we added 
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organizational units and cost types. Since we also had detailed information on staff, we split 
this cost type into four sub-cost components (nursing, physician, therapist, and social 
counselling). Table 3 shows the developed cost matrix.  
Data Analysis 
Continuous and categorical patient characteristics are presented with mean and standard 
deviation (sd) or median and quartiles (lower, upper), and relative and absolute frequencies. 
PC and UC groups were compared using Mann-Whitney-Wilcoxon or chi-squared tests for 
continuous and categorical variables.  
The crude cost data (see appendix II) are presented with mean and standard deviation for 
each group and compared between PC and UC using linear regression with robust standard 
error. We used bootstrapping with 2’000 repetitions to correct for bias and calculate 95% 
confidence intervals (95% CI).34  Cost data were adjusted using inverse probability weighting 
based on propensity scores. This method is used widely in observational studies to adjust for 
cofounding effects and to control for selection bias and has been shown to improve estimates 
of the effect of an intervention on costs.30-32 We derived propensity scores through a logistic 
regression with “age”, “marital status” (as binary variable, married yes/no), “insurance class”, 
“primary diagnosis” and “location prior to entry” (e.g. home, other hospitals, psychiatric clinic) 
as covariates. For the inverse probability weighting, we used stabilized weights and calculated 
potential outcome means (POM) and average treatment effects (ATE) based on weighted 
linear regression.32 P-values were derived using the bias-corrected point estimate and the 
bootstrap standard errors with a normal approximation. 
As a sensitivity analysis, we used generalized linear models with gamma distribution and log-
link to fit the cost data. The estimated model coefficients are presented on the exponentiated 
scale and can be interpreted as mean per group and as mean ratio between groups. Crude 
estimates were calculated from intercept only models for each group and a model with group 
as covariate (see appendix V). The analysis was adjusted using inverse probability weighting 
by propensity scores as described above (see appendix III+IV).  
To allow for international comparisons, instead of the 25% criteria to define PC exposure, we 
followed the 3-day criteria from admission followed by others35 and performed further sensitivity 
analyses. 
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Results  
Patient Characteristics  
Patients in the PC group were younger than those in UC (64.7 years vs. 70.8 years, p<0.001). 
The majority were male and married. Over three quarters of patients from both groups had 
public insurance plans. Primary diagnoses differed between UC and PC significantly 
(p<0.001). More than half of UC patients (377, 59%) died of a cardiovascular disease followed 
by malignant neoplasms (108, 17%) while most of the PC patients died of malignant neoplasms 
(77, 74%) followed by cardiovascular diseases (12, 12%). In UC, two thirds of patients (423, 
66%) were admitted to the hospital from home and 193 (30%) from other hospitals, while within 
PC, 87 (84%) patients were admitted from home and only 10 (10%) from another hospital. 
Admissions to the ER were significantly higher for UC patients (474, 74%) than for PC (62, 
60%), as well as to the ICU, where 420 (65%) UC patients were admitted at least once, while 
only 27 (26%) PC patients were admitted there (p<0.001). Moreover, there was a significant 
difference in average length of stay of 8.8 days (p<0.001) with PC patients having longer stays 
(refer to Table 4 for patient characteristics).  
Financial Analysis 
All cost components: With respect to all cost components aggregated, total costs over the 
whole stay were relatively similar for PC (CHF 38’381, 95%CI 30’230 to 48’132) and UC 
patients (CHF 41’158, 95%CI 36’191 to 47’731) leading to a mean difference of CHF -2’777 
with a wide 95% confidence interval (-12’713 to 8’506) that included 0 (Table 5). Average daily 
costs for a PC patient were significantly lower (CHF -3’244, 95%CI -3’811 to -2’631) than for 
UC (Table 6).  
Organizational units: The results presented in Table 5 and 6 show a clear trend that PC 
patients had lower total costs than UC patients in radiology (CHF -1’457, 95%CI -1'937 to -
1'027), ICU (CHF -8’895 95%CI -12'734 to -5'772) and surgery (CHF -1’555, 95%CI -3'529 to 
731). The same was true for average daily costs in the same organizational units. The opposite 
effect was observed for hotel costs (total costs CHF 1’701, 95%CI 1'204 to 2'272 and average 
daily costs CHF 16, 95%CI 1 to 33). Ward costs were lower in terms of average daily costs for 
PC than for UC patients (CHF -814 CHF, 95%CI -1'176 to -444), but were higher in terms of 
total costs (CHF 7’385 95%CI 596 to 14'785). Emergency room costs were similar in both 
groups. 
Cost types: The effect on total and average daily costs showed the same direction for catering, 
laboratory, material, other, pharmacy and room costs. Laboratory, material, pharmacy, and 
other costs were cheaper for PC patients, while the other costs showed the opposite trend 
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(Table 5 and 6). Total patient management and staff costs were similar in both groups, whereas 
average daily costs were lower in PC.  
Staff detail: Nursing (costs per day: CHF 180, 95%CI -137 to 550; total costs: CHF 9’625, 
95%CI 5'300 to 14'763), social counselling (costs per day: CHF 48, 95%CI 28 to 66; total costs: 
CHF 282, 95%CI 164 to 415) and therapist costs (costs per day: CHF 60, 95%CI 33 to 105; 
total costs: CHF 347, 95%CI 134 to 609) were higher for PC patients than for UC patients. The 
opposite effect was observed for physicians, who had lower average daily costs (CHF -1’644, 
95%CI -2'177 to -1'139) and total costs (CHF -8’288, 95%CI -13'021 to -3'918) for PC patients 
compared to UC patients.  
Sensitivity Analyses 
The results remained similar when a generalized linear model with gamma distribution and log-
link was used instead of the linear model (see appendix III-IV). Total costs were similar in both 
groups with a mean ratio of PC vs UC of 0.94 (95%CI 0.68 to 1.18), whereas costs per day 
were reduced in the PC group by 58% (95% CI 49 to 66%). 
With the 3-day after admission criteria defining PC exposure (n=41), average daily costs were 
not much affected by the different grouping, but total costs shifted in favor of PC—overall costs 
were e.g. reduced by CHF 14’461 (5’203 to 25’721) in PC compared to UC; in the main analysis 
the groups were closer together. The main drivers for this difference were surgery, ward and 
staff costs, which were all shifted in favor of PC (appendix VI-VII). 
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Discussion 
Our analysis suggests that PC reduces average daily costs but may not reduce total costs as 
patients stayed longer. A reduction of average daily costs by PC has been observed before.3,5-
7,11-13,15  but may not be as significant for policymakers than a reduction in total costs. A 
significant reduction of total costs was only seen when PC exposure was defined as ‘referral 
to PC within 3 days from admission to the hospital’. The exposure chosen in our study (based 
on a 25% threshold on the exposure to PC) may explain why compared to international 
trends,3,4,7,9,13,15 total costs in our sample were not significantly lower for PC.  In particular, long-
stayers with high total costs who did not start PC right away may still be considered as receiving 
PC in our setting. 
Individual cost components, which are significantly higher for PC compared to UC patients, 
are hotel (organizational unit), catering and room (cost types), as well as nursing, social 
counselling and therapist costs (staff detail). In contrast to lower cost components such as 
radiology, laboratory, material and pharmacy costs, the higher costs in PC for direct care such 
as nursing staff and therapists may be those that contribute to increased quality of care for the 
patient and their family members. Catering and room cost differences between PC and UC are 
similar to the results of the study (room and board costs) from May et al. (2015). Only Penrod 
et al. (2010) examined the differences in total nursing costs. However, an opposite trend 
resulting in significant lower costs for PC patients than for UC patients was reported. The 
differences in the cost components such as materials, physician, social counselling and other 
therapists have not been reported to date. 
Like in many other developed countries, economic pressure also weighs on the Swiss 
healthcare sector. Therefore, hospitals increasingly have to justify their health offers, including 
whether and how PC contributes to in-hospital costs.35,37 Our in-depth approach can 
comprehensively show that the cost components of PC which are significantly higher are direct 
costs due to a longer hospital stay. However, length of stay in hospital depends largely on the 
availability of surrounding healthcare offers such as mobile home care teams and nursing 
homes. Thus, cost components driven by the length of stay are directly dependent on the 
possibility to transfer complex patients to another setting of care when patients are stable and 
which may not be regarded as valid factors/ measurements for cost evaluation studies in end 
of life and PC. Keeping a balance between the quality of care at the end of life and its incurred 
costs will be a challenging task for healthcare systems in the near future.12 
There are a number of limitations to our study. In particular, the generalizability of the results 
might be questioned. Data was collected from one University hospital and thus does not 
contain cost data from other health settings including other hospitals, hospices, as well as 
different hospital types such as private, non-profit and public hospitals. An international or inter-
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institutional comparison may provide a better basis to further understand the cost saving 
impact, as well as to support discussions between stakeholders, such as in reimbursement 
negotiations. In this case, an agreed set of cost components (leaving out components that are 
directly linked to length of stay) is needed as a common basis. Whether some types of cost 
data are preferable to others could be the focus of future studies. Moreover, increasing the 
sample size by adding data from other years could have help increase power in our 
comparisons. To avoid bias, future research should also include all patients’ discharges (alive 
and dead).36 In addition, a prospective longitudinal design across settings of care may provide 
more comprehensive results. Costs in retrospective studies might appear higher because PC 
is added to conventional therapy. As an example, this study defined a PC patient as a patient 
who receives PC on the PC ward or a PC consultation only. However, we did not distinguish 
between both interventions. Another limitation might be the potential self-selection bias, which 
“arises when a rule other than simple random sampling is used to sample the underlying 
population”,37 however, we tried to reduce this problem using simple exclusion criteria. With 
respect to the study’s statistical methodology, propensity-score weighting might fail to adjust 
adequately for unmeasured variables and we only measured a limited set of confounders. 
Psychosocial factors and unobserved complications in a patient’s condition throughout the 
hospital stay may also affect the cost estimates. However, we tried to provide a valid 
comparison between PC and UC patients using all available data at the time of hospital 
admission.16 The development of the cost matrix can be questioned but the data from the 
accounting system leave little room for cost allocation varieties. The advantage of this matrix 
is the option to analyze individual costs blocks separately (e.g. only ward costs). The 
correlation of costs and quality of care needs to be discussed in further research. Finally, the 
definition of PC based on a 25% threshold on the exposure to PC may have led to the dilution 
of the sample by patients that did not profit from the PC intervention, including long-stayers 
with high total costs. Other authors17,35 have employed referral within a few days from 
admission as adequate timeframes, which have shown that the earlier the exposure the greater 
the chances of positive impacting on cost. Indeed, such an approach favored the PC group in 
our analysis with respect to total costs. 
Conclusion 
We contribute to the growing literature a comprehensive analysis of hospital cost components 
from three different perspectives: (1) organizational units (2) cost types and (3) staff detail.  We 
identified main triggers that influence the cost components in PC and UC patients, which can 
be the basis for comprehensive and reliable cost analyses. Such analysis enhances 
transparency for internal and external stakeholders and can serve as a potential controlling 
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instrument. The recognition of these differences between and within costs can be an 
advantage to justify health offers in financially tense healthcare industries in the future.  
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Tables and Figures 
 
 
Figure 1: Exclusion flowchart for initial sample list 
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Table 1: Applied hospital databases  
Nr. Hospital database Data 
1 Patient characteristics Administrative and medical patient data  
2 Patient process  Inhospital movements of patients 
3 Activity records Rendered services and items 
4 Cost unit accounting Costs per unit 
5 Medication database 1 Medication data for regular wards 
6 Medication database 2 Medication data for emergency room 
7 Medication database 3 Medication data for ICU 
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Table 2: Cost components from existing literature 
Cost components  Number of studies*   
Studies with costs lower in 
PC vs. UC*  
 
Studies with costs higher 
in PC vs. UC*  
 
Assigned cost 
categories 
Total costs per day 11 (9) 10 (8) 1 (1) total 
Total costs 11 (8) 10 (8) 1 (0) total 
Pharmacy costs 10 (5) 8 (4) 2 (1) cost type 
Laboratory costs 10 (5) 9 (6) 1 (0) cost type 
Imaging costs 10 (3) 9 (2) 1 (1) organizational unit 
Total direct costs 9 (5) 7 (5) 2 (0) total 
ICU costs 8 (5) 8 (5) 0 (0) organizational unit 
Direct costs 5 (4) 4 (4) 1 (0) total 
Total direct costs per day 3 (3) 3 (3) 0 (0) total 
Direct costs per day 2 (2) 2 (2) 0 (0) total 
Management costs 2 (2) 1 (1) 1 (1) cost type 
Procedure costs 2 (1) 2 (1) 0 (0) cost type 
Room and board costs 2 (1) 1 (0) 1 (1) cost type 
Test costs 2 (0) 2 (0) 0 (0) cost type 
Total variable costs per day 1 (1) 1 (1) 0 (0) total 
Nursing costs 1 (1) 1 (1) 0 (0) cost type 
Total variable costs 1 (0) 1 (0) 0 (0) total 
Supplies and equipment costs 1 (0) 1 (0) 0 (0) cost type 
* The number of studies appears in parentheses, which found significantly differences between costs  
  
 
 
20 
 
Table 3: Cost matrix 
Cost components 
Cluster 1 "Organizational units" 
Emergency 
room  
costs 
Hotel costs Radiology costs ICU costs 
Surgery 
room  
costs 
Ward costs 
C
lu
st
er
 2
  
"C
os
t t
yp
es
" 
 
Catering costs   +         
Laboratory costs +   + + + + 
Material costs +   + + + + 
Other costs + + + + + + 
Patient management costs + + + + + + 
Pharmacy costs +   + + + + 
Room costs   +         
Staff costs +   + + + + 
C
lu
st
er
 3
  
"S
ta
ff 
de
ta
il"
 Nursing costs  +   + + + + 
Physician costs +   + + + + 
Social counselling costs 
       +   + 
Therapist costs       +   + 
Grey marked fields represent cost components already analyzed in previous studies (Table 2).  
The “+” indicates that these cost types are part of the organizational unit and the cost type or staff detail.    
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Table 4: Patient characteristics 
Results UC patients  (n = 642) 
PC patients  
(n = 104) p-value 
Age (years) 
Mean (sd) 70.8 (14.0) 64.7 (14.3) 
<0.001 
Median (quartiles) 73.0 (62.0, 82.0) 67.0 (55.5, 75.0) 
Gender 
Female 276 (43.0 %) 44 (42.3 %) 
0.896 
Male 366 (57.0 %) 60 (57.7 %) 
Marital status 
Married 359 (55.9 %) 65 (62.5 %) 
0.035 
Divorced 78 (12.1 %) 11 (10.6 %) 
Single 78 (12.1 %) 19 (18.3 %) 
Widowed 108 (16.8 %) 9 (8.7 %) 
Unknown 19 (3.0 %) 0 (0.0 %) 
Citizenship 
Swiss 576 (89.7 %) 86 (82.7 %) 
0.152 
Italian 16 (2.5 %) 6 (5.8 %) 
German 9 (1.4 %) 2 (1.9 %) 
Other 41 (6.4 %) 10 (9.6 %) 
Insurance class 
Public 525 (81.8 %) 81 (77.9 %) 
0.291 Semi-private 95 (14.8 %) 21 (20.2 %) 
Private 22 (3.4 %) 2 (1.9 %) 
Primary diagnosis 
Malignant neoplasms 108 (16.8 %) 77 (74.0 %) 
<0.001 
Cardiovascular diseases  377 (58.7 %) 12 (11.5 %) 
Neurological diseases 23 (3.6 %) 2 (1.9 %) 
Infectious diseases 57 (8.9 %) 5 (4.8 %) 
Gastrointestinal diseases 43 (6.7 %) 4 (3.8 %) 
Others 34 (5.3 %) 4 (3.8 %) 
Location prior  
to entry 
Home 423 (65.9 %) 87 (83.7 %) 
<0.001 
Other hospital 193 (30.1 %) 10 (9.6 %) 
SPITEX* 6 (0.9 %) 5 (4.8 %) 
Elderly home 7 (1.1 %) 1 (1.0 %) 
Psychatric clinic 2 (0.3 %) 1 (1.0 %) 
Penal institution 1 (0.2 %) 0 (0.0 %) 
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Other 10 (1.6 %) 0 (0.0 %) 
Inhospital 
admission 
Emergency room 
admission 474 (73.8 %) 62 (59.6 %) 0.003 
ICU admission  420 (65.4 %) 27 (26.0 %) <0.001 
Radiology admission 530 (82.6 %) 91 (87.5 %) 0.210 
Surgery room admission 477 (74.3 %) 53 (51.0 %) <0.001 
Ward admission 642 (100.0 %) 104 (100.0 %) - 
ALOS Mean (sd) 7.2 (9.5) 16.0 (12.0) <0.001 
Casemix-Index Mean (sd) 2.791(3.515) 1.991 (1.464) <0.001 
* Home along with ambulatory nursing care 
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Table 5: Total costs 
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Table 6: Average daily costs 
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To
ta
l c
os
ts
 
pe
r d
ay
To
ta
l c
os
ts
Ph
ar
m
ac
y c
os
ts
La
bo
ra
to
ry
 
co
st
s
Im
ag
in
g 
co
st
s
To
ta
l d
ire
ct
 
co
st
s
IC
U 
co
st
s
Di
re
ct
 co
st
s
To
ta
l d
ire
ct
 
co
st
s p
er
 d
ay
Di
re
ct
 co
st
s 
pe
r d
ay
Ma
na
ge
m
en
t 
co
st
s
Pr
oc
ed
ur
e 
co
st
s
Ro
om
 an
d 
bo
ar
d 
co
st
s
Te
st
 co
st
s
To
ta
l v
ar
iab
le 
co
st
s 
pe
r d
ay
Nu
rs
in
g 
co
st
s
To
ta
l v
ar
iab
le 
co
st
s
Su
pp
lie
s a
nd
 
eq
ui
pm
en
t c
os
ts
2003 Smith et al. USA 05.2000 - 12.2000
Retrospective case-
control analysis
38
discharges
38
discharges *** *** ***
2004 Cowan et al. USA 07.2000 - 06.2001
Retrospective cohort 
analysis
164
discharges
152
discharges ***
2006 Penrod et al. USA 10.2002 - 09.2003
Retrospective 
observational analysis
82
discharges
232
discharges ***
2007 Ciemins et al. USA 01.2004 - 12.2006
Retrospective matched 
ohort analysis
27
discharges
128
discharges *** ***
2008 Bendaly et al. USA 01.2005 - 12.2005
Retrospective 
analysis
61
discharges
55
discharges
2008 Gade et al. USA 06.2002 - 12.2003
Prospective 
randomized trial
275
discharges
237
discharges ***
2008 Hanson et al. USA 07.2002 . 06.2005
Prospective 
observational
analysis
104
discharges
1'813
discharges **
2'630 
live discharges
18'427 
live discharges *** ** *** *** *** *** *** ***
2'278 
death discharges
2'124 
death 
discharges
*** *** ** *** *** *** *** *** ***
2010 Penrod et al. USA 10.2004 - 09.2006
Retrospective 
observational analysis
606
discharges
2'715
discharges sig. sig. sig. sig. sig. sig.
89 
live discharges
57
discharges ***
37 b)
death discharges 
57 
discharges **
290 
live discharges
1'427 
live discharges *** ** ***
185 
death discharges
149 
deaths 
discharges
*** ** **
756
live discharges
731
live discharges
1'059
death discharges
1'059
discharges
1'177 
live discharges
3'531 
live discharges sig. sig. sig.
300 
death discharges
3'531
death 
discharges
sig. sig. sig. sig. sig. sig. sig. sig.
1'816 
live discharged 
33'574 
live discharged
572
death discharges 
1'246
death 
discharges
2015 May et al. USA 01.2007 - 12.2011
Prospective 
observational cohort 
analysis
256
discharges
713
discharges *** c) ***
2018 May et al. USA 01.2009 - 12.2015
Retrospective 
cohort analysis
1139
discharges
5'622 
discharges ***
11 (9) 11 (8) 10 (5) 10 (5) 10 (3) 9 (5) 8 (5) 5 (4) 3 (3) 2 (2) 2 (2) 2 (1) 2 (1) 2 (0) 1 (1) 1 (1) 1 (0) 1 (0)
10 (8) 10 (8) 8 (4) 9 (6) 9 (2) 7 (5) 8 (5) 4 (4) 3 (3) 2 (2) 1 (1) 2 (1) 1 (0) 2 (0) 1 (1) 1 (1) 1 (0) 1 (0)
1 (1) 1 (0) 2 (1) 1 (0) 1 (1) 2 (0) 0 (0) 1 (0) 0 (0) 0 (0) 1 (1) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
a) Combined analysed cost types
b) Patients not from PC unit, but from PC within cardiology, geriatric, and oncology wards
c) PC intervention within at least 6 days has a positive significant cost effect (p=0.04); within 2 days (p=0.002) the study distinguishes between patients from PC unit (p=0.07) and PC consultation (p<0.001)
d) The study distinguishes between patients from PC unit (p=0.07) and PC consultation (p<0.001)
Number of analyses (number of significant studies)
Number of analyses with costs/days PC < UC (number of significant studies)
Number of analyses with costs/days  PC > UC (number of significan studies)
Number of analyses with costs/days  PC = UC (number of significant studies)
Retrospective 
case-control  
analysis
2015 McCarthy USA 01.2009-06.2012
Retrospective  
observational
study design
2013 Whitford et al. USA 01.2003 - 12.2008
01.2004 - 
12.2007
Retrospective 
analysis
2013 Starks et al. USA 01.2005 - 12.2008
Retrospective  
observational 
analysis
01.2007-
06.2007
Retrospective 
cohort analysis
2011 Morrison et al. USA
01.2002 - 
12.2004
Retrospective 
analysis
2010 Simoens et al. Belgium
Intervention Group
(Palliative Care Patients)
*** a)
2008 Morrison et al. USA
Year of Publication Author(s) Country
Study 
Period Design
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Appendix II: Crude Data 
Total costs per patient in CHF 
    
Total  
(N = 746) 
UC patients 
(N = 632) 
PC patients 
(N=104) PC vs UC patients p-Value 
Total 
mean* 37'602 (52'825) 
38'262 
(56'098) 33'529 (24'064) 
-4'733 (-15'697, 
6'231) 0.400 
median** 
21'455 
[7'904, 
45'339] 
20'625 [7'305, 
45'315] 
28'619 [16'780, 
46'482] 
0.576 (0.517 to 
0.634) 0.012 
Cluster 1  
"Organizational units" 
        
Emergency  
room 
mean* 789 (739) 799 (733) 731 (771) -68.2 (-221 to 85.1) 0.380 
median** 742 [0.000, 1303] 
770 [0.000, 
1299] 504 [0.000, 1333] 
0.462 (0.404 to 
0.521) 0.200 
Hotel 
mean* 1'285 (1'658) 1'017 (1'426) 2'941 (2'000) 
1'924 (1'609 to 
2'239) 0.000 
median** 563 [242, 1694] 
424 [218, 
1147] 2498 [1489, 4031] 
0.860 (0.815 to 
0.894) 0.000 
ICU mean* 9'586 (23'631) 
10'920 
(25'176) 1353 (3'871) 
-9567 (-14'426 to -
4'709) 0.000 
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median** 
1'116 
[0.000, 
8755] 
2'381 [0.000, 
10965] 
0.000 [0.000, 
0.000] 
0.268 (0.222 to 
0.322) 0.000 
Radiology 
mean* 2'408 (4'651) 2'541 (4'935) 1'591 (2'020) -950 (-1913 to 13.8) 0.050 
median** 955 [215, 2079] 
955 [206, 
2113] 916 [333, 1934] 
0.499 (0.440 to 
0.558) 0.970 
Surgery 
mean* 4'083 (9'948) 4'447 (10'561) 1'838 (3'959) 
-2'609 (-4'666 to -
552) 0.013 
median** 634 [0.000, 2125] 
765 [0.000, 
2425] 129 [0.000, 1216] 
0.370 (0.316 to 
0.428) 0.000 
Ward 
mean* 19'450 (28'458) 
18'538 
(29'681) 25'076 (18'387) 
6'538 (647 to 
12'428) 0.030 
median** 
9'107 
[2'990, 
24'929] 
8'025 [2624, 
21568] 
21'532 [9'605, 
35'612] 
0.695 (0.638 to 
0.746) 0.000 
Cluster 2  
"Cost types" 
        
Catering 
mean* 303 (494) 235 (434) 720 (622) 485 (388 to 581) 0.000 
median** 
61.7 
[0.000, 
421] 
23.9 [0.000, 
289] 667 [269, 961] 
0.813 (0.766 to 
0.852) 0.000 
Laboratory mean* 1'819 (3'490) 1'893 (3'675) 1'365 (1'945) -528 (-1251 to 196) 0.150 
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median** 623 [178, 1'989] 
598 [173, 
2'038] 732 [223, 1'631] 
0.500 (0.441 to 
0.559) 1.000 
Material 
mean* 2'431 (6'032) 2'741 (6'436) 520 (1'070) 
-2'221 (-3'463 to -
978) 0.000 
median** 243 [65.5, 1'864] 
274 [61.5, 
2'559] 174 [74.4, 461] 
0.432 (0.374 to 
0.491) 0.025 
Other 
mean* 3'474 (9'165) 3'752 (9'787) 1'758 (2'837) 
-1'994 (-3'892 to -
96.3) 0.039 
median** 754 [0.000, 2'630] 
788 [0.000, 
2'658] 356 [0.000, 2'600] 
0.470 (0.412 to 
0.529) 0.320 
Patient-
management 
mean* 196 (145) 196 (143) 194 (160) -2.32 (-32.5 to 27.9) 0.880 
median** 188 [147, 202] 188 [147, 204] 181 [147, 188] 
0.404 (0.348 to 
0.463) 0.002 
Pharmacy 
mean* 3'479 (10'153) 3'689 (10'764) 2'180 (4'737) 
-1'509 (-3'615 to 
596) 0.160 
median** 525 [155, 1'996] 
503 [146, 
2'010] 771 [216, 1'982] 
0.531 (0.471 to 
0.589) 0.320 
Room 
mean* 787 (1'205) 586 (1'021) 2'027 (1'487) 1'441 (1'213 to 1'669) 0.000 
median** 266 [60.2, 1051] 
189 [60.2, 
620] 1681 [932, 2773] 
0.869 (0.826 to 
0.902) 0.000 
Staff mean* 25'115 (33'814) 
25'171 
(35'760) 24'766 (17'652) 
-405 (-7'426 to 
6'616) 0.910 
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median** 
14'757 
[5'652, 
30'512] 
13'032 [4'952, 
30'432] 
20'195 [11'358, 
33'262] 
0.606 (0.547 to 
0.662) 0.000 
Cluster 3 
"Staff detail" 
        
Nursing 
mean* 9'046 (12'110) 7'891 (11'652) 16'174 (12'496) 
8'283 (5'840 to 
10'726) 0.000 
median** 
4'414 
[1'978, 
11'718] 
3'787 [1'659, 
8'775] 
12'902 [6'310, 
22'164] 
0.773 (0.720 to 
0.817) 0.000 
Physician 
mean* 15'536 (27'687) 
16'828 
(29'532) 7'560 (6'535) 
-9'268 (-14'979 to -
3'558) 0.002 
median** 
5'863 
[2'210, 
17'484] 
60'71 [2'013, 
19'690] 5'642 [3'323, 9'306] 
0.477 (0.418 to 
0.537) 0.450 
Social 
counselling 
mean* 123 (228) 92.1 (189) 314 (331) 222 (177 to 266) 0.000 
median** 35.4 [11.8, 133] 
29.5 [11.8, 
82.6] 204 [92.0, 412] 
0.823 (0.775 to 
0.862) 0.000 
Therapist 
mean* 427 (866) 377 (870) 737 (771) 360 (182 to 538) 0.000 
median** 
51.3 
[0.000, 
520] 
0.000 [0.000, 
437] 487 [181, 1018] 
0.728 (0.676 to 
0.773) 0.000 
* Mean (sd), mean difference (95% CI), linear regression with robust standard errors 
**Median [lower quartile, upper quartile], Mann-Whitney statistic (95% CI), Wilcoxon-Mann-Whitney test 
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Costs per day per patient in CHF 
    
Total  
(N = 746) 
UC patients 
(N = 632) 
PC patients 
(N=104) PC vs UC patients p-Value 
Total 
mean* 5'194 (5'511) 5'699 (5'777) 2'073 (759) 
-3'626 (-4'740 to -
2'511) 0.000 
median** 
3'480 
[2'048, 
6'476] 
4'046 [2'361, 
7'124] 1'849 [1'576, 2'314] 
0.184 (0.144 to 
0.232) 0.000 
Cluster 1  
"Organizational units" 
        
Emergency  
room 
mean* 652 (647) 669 (652) 542 (604) -127 (-261 to 6.87) 0.060 
median** 
558 
[0.000, 
1048] 
591 [0.000, 
1060] 406 [0.000, 921] 
0.433 (0.376 to 
0.492) 0.026 
Hotel 
mean* 156 (77.2) 152 (80.7) 186 (39.8) 34.0 (18.2 to 49.9) 0.000 
median** 163 [101, 201] 152 [101, 201] 188 [166, 203] 
0.661 (0.603 to 
0.714) 0.000 
ICU mean* 2782 (4204) 3136 (4391) 598 (1506) 
-2538 (-3392 to -
1684) 0.000 
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median** 
819 
[0.000, 
4023] 
1'274 [0.000, 
4'563] 
0.000 [0.000, 
0.000] 
0.267 (0.221 to 
0.320) 0.000 
Radiology 
mean* 1'110 (2'693) 1'178 (2'861) 690 (1'151) 
-487 (-1'045 to 
70.9) 0.090 
median** 394 [178, 843] 402 [178, 867] 355 [145, 656] 
0.471 (0.412 to 
0.530) 0.330 
Surgery 
mean* 2114 (4979) 2290 (5280) 1026 (2101) 
-1265 (-2294 to -
235) 0.016 
median** 
565 
[0.000, 
1673] 
652 [0.000, 
1769] 129 [0.000, 795] 
0.361 (0.307 to 
0.419) 0.000 
Ward 
mean* 2'434 (2'880) 2'576 (3'074) 1'556 (530) 
-1'020 (-1'614 to -
427) 0.000 
median** 
1'557 
[1'030, 
2'630] 
1'598 [992, 
3'036] 1'394 [1'183, 1'770] 
0.449 (0.391 to 
0.509) 0.100 
Cluster 2  
"Cost types" 
        
Catering 
mean* 22.1 (24.3) 18.7 (23.4) 43.1 (18.3) 24.5 (19.7 to 29.2) 0.000 
median** 
12.6 
[0.000, 
43.1] 
4.79 [0.000, 
38.1] 48.5 [34.1, 56.3] 
0.800 (0.752 to 
0.840) 0.000 
Laboratory mean* 273 (417) 294 (443) 143 (138) -150 (-237 to -64.5) 0.000 
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median** 153 [89.4, 288] 163 [100, 306] 107 [59.0, 183] 
0.351 (0.297 to 
0.409) 0.000 
Material 
mean* 1'174 (2'764) 1'342 (2'944) 142 (229) 
-1199 (-1767 to -
632) 0.000 
median** 117 [47.2, 643] 
131 [47.8, 
916] 83.5 [40.3, 151] 
0.374 (0.319 to 
0.434) 0.000 
Other 
mean* 856 (1975) 964 (2107) 194 (286) -769 (-1176 to -363) 0.000 
median** 
242 
[0.000, 
937] 
321 [0.000, 
1032] 53.0 [0.000, 292] 
0.372 (0.318 to 
0.430) 0.000 
Patient-
management 
mean* 62.4 (66.5) 69.2 (68.7) 20.3 (23.5) -49.0 (-62.3 to -35.6) 0.000 
median** 36.6 [15.7, 93.8] 
46.9 [19.2, 
96.9] 12.6 [7.53, 22.1] 
0.207 (0.165 to 
0.257) 0.000 
Pharmacy 
mean* 673 (2087) 760 (2235) 138 (277) -622 (-1053 to -191) 0.005 
median** 127 [41.3, 359] 
151 [49.8, 
423] 51.3 [24.8, 91.0] 
0.300 (0.250 to 
0.357) 0.000 
Room 
mean* 71.8 (52.6) 63.6 (51.4) 122 (24.7) 58.5 (48.5 to 68.6) 0.000 
median** 70.5 [15.0, 114] 
60.2 [13.6, 
102] 127 [108, 142] 
0.852 (0.807 to 
0.887) 0.000 
Staff mean* 3'540 (2'860) 3'836 (2'959) 1'719 (881) 
-2'117 (-2'691 to -
1'543) 0.000 
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median** 
2'770 
[1'574, 
4'887] 
3'171 [1'782, 
5'134] 1'501 [1'159, 1'893] 
0.208 (0.166 to 
0.259) 0.000 
Cluster 3 
"Staff detail" 
        
Nursing 
mean* 1'217 (803) 1'238 (834) 1'089 (564) -149 (-315 to 17.6) 0.080 
median** 1'019 [738, 1'479] 
1'040 [724, 
1'519] 920 [772, 1'231] 
0.461 (0.402 to 
0.520) 0.020 
Physician 
mean* 3'315 (3'461) 3'600 (3'630) 1'554 (1'000) 
-2'046 (-2'749 to -
1'343) 0.000 
median** 2'129 [948, 4'659] 
2'409 [1'007, 
5'083] 1'264 [771, 2'136] 
0.320 (0.268 to 
0.377) 0.000 
Social 
counselling 
mean* 32.4 (54.1) 27.0 (52.9) 65.5 (49.7) 38.5 (27.6 to 49.4) 0.000 
median** 7.38 [5.90, 32.3] 
6.55 [5.90, 
14.0] 58.1 [28.9, 81.7] 
0.823 (0.775 to 
0.862) 0.000 
Therapist 
mean* 64.7 (78.8) 57.8 (76.8) 107 (77.5) 49.6 (33.6 to 65.5) 0.000 
median** 
51.3 
[0.000, 
121] 
0.000 [0.000, 
115] 108 [87.0, 131] 
0.684 (0.630 to 
0.732) 0.000 
* Mean (sd), mean difference (95% CI), linear regression with robust standard errors 
**Median [lower quartile, upper quartile], Mann-Whitney statistic (95% CI), Wilcoxon-Mann-Whitney test 
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Appendix III: Comparison of costs per day of PC vs UC using generalized linear model with gamma 
distribution and log-link adjusted by inverse probability weighting. 
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Appendix IV: Comparison of total costs of PC vs UC using generalized linear model with gamma 
distribution and log-link adjusted by inverse probability weighting.  
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Appendix V:  Crude analysis of total costs and costs per day using generalized linear models with gamma 
distribution and log-link 
  
Palliative care costs  
(95% CI) 
Usual care costs  
(95% CI) 
Mean ratio  
(95% CI) P-value 
Total costs     
Total 33640 (29211 to 38428) 38300 (34333 to 42991) 0.88 (0.74 to 1.04) 0.15 
Cluster 1: "Organizational units"    
Emergency room 736 (585 to 877) 798 (741 to 857) 0.92 (0.73 to 1.13) 0.45 
Hotel 2947 (2598 to 3378) 1020 (910 to 1127) 2.90 (2.46 to 3.45) <0.001 
ICU 1431 (719 to 2274) 10955 (9138 to 13097) 0.13 (0.06 to 0.22) <0.001 
Radiology 1604 (1236 to 2047) 2542 (2186 to 2935) 0.63 (0.46 to 0.82) 0.002 
Surgery 1888 (1172 to 2744) 4468 (3642 to 5341) 0.42 (0.26 to 0.64) <0.001 
Ward 25143 (21872 to 28781) 18564 (16401 to 20933) 1.36 (1.12 to 1.61) 0.001 
Cluster 2: "Cost types"    
Catering 723 (612 to 851) 236 (201 to 267) 3.07 (2.47 to 3.81) <0.001 
Laboratory 1379 (1045 to 1785) 1899 (1635 to 2211) 0.73 (0.53 to 0.99) 0.047 
Material 534 (361 to 784) 2750 (2269 to 3278) 0.19 (0.13 to 0.30) <0.001 
Other 1774 (1283 to 2368) 3764 (3091 to 4616) 0.48 (0.32 to 0.68) <0.001 
Patientmanagement 195 (175 to 242) 196 (188 to 211) 0.99 (0.87 to 1.20) 0.88 
Pharmacy 2248 (1437 to 3286) 3718 (2973 to 4657) 0.60 (0.37 to 0.95) 0.036 
Rooms 2032 (1780 to 2352) 588 (511 to 665) 3.46 (2.85 to 4.20) <0.001 
Staff 24838 (21513 to 28305) 25187 (22539 to 28153) 0.99 (0.83 to 1.17) 0.89 
Cluster 3: "Staff detail"    
Nursing 16213 (13985 to 18681) 7899 (7055 to 8847) 2.06 (1.71 to 2.46) <0.001 
Physician 7608 (6432 to 8903) 16852 (14747 to 19336) 0.45 (0.36 to 0.56) <0.001 
Social counseling 315 (255 to 383) 93 (80 to 109) 3.42 (2.64 to 4.37) <0.001 
Therapist 739 (591 to 893) 378 (319 to 453) 1.97 (1.49 to 2.54) <0.001 
Total costs per 
day     
Total 2077 (1938 to 2228) 5699 (5279 to 6171) 0.36 (0.33 to 0.41) <0.001 
Cluster 1: "Organizational units"    
Emergency room 546 (432 to 660) 668 (620 to 721) 0.81 (0.64 to 1.01) 0.08 
Hotel 186 (178 to 194) 152 (146 to 158) 1.22 (1.16 to 1.30) <0.001 
ICU 624 (339 to 928) 3143 (2824 to 3511) 0.20 (0.11 to 0.30) <0.001 
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Surgery 1047 (673 to 1499) 2301 (1917 to 2735) 0.46 (0.29 to 0.68) <0.001 
Radiology 699 (498 to 948) 1182 (960 to 1412) 0.59 (0.40 to 0.86) 0.007 
Ward 1558 (1462 to 1666) 2577 (2355 to 2831) 0.60 (0.54 to 0.68) <0.001 
Cluster 2: "Cost types"    
Catering 43 (39 to 47) 19 (17 to 20) 2.31 (2.02 to 2.61) <0.001 
Laboratory 144 (119 to 172) 295 (262 to 331) 0.49 (0.40 to 0.62) <0.001 
Material 145 (109 to 198) 1345 (1127 to 1575) 0.11 (0.08 to 0.15) <0.001 
Other 195 (144 to 253) 966 (818 to 1139) 0.20 (0.14 to 0.28) <0.001 
Patientmanagement 20 (17 to 25) 69 (64 to 75) 0.29 (0.23 to 0.37) <0.001 
Pharmacy 142 (91 to 199) 764 (612 to 941) 0.18 (0.12 to 0.29) <0.001 
Room 122 (118 to 127) 64 (60 to 68) 1.92 (1.78 to 2.07) <0.001 
Staff 1723 (1567 to 1907) 3834 (3607 to 4084) 0.45 (0.40 to 0.51) <0.001 
Cluster 3: "Staff detail"    
Nursing 1091 (989 to 1205) 1238 (1179 to 1312) 0.88 (0.79 to 0.98) 0.024 
Physician 1559 (1381 to 1762) 3599 (3341 to 3897) 0.43 (0.37 to 0.50) <0.001 
Social counseling 66 (56 to 76) 27 (23 to 31) 2.42 (1.96 to 3.00) <0.001 
Therapist 108 (95 to 125) 58 (52 to 64) 1.86 (1.58 to 2.26) <0.001 
 
 
 
 
 
 
 
39 
 
Appendix VI. Comparison of total costs of PC vs UC defining PC exposure when referral to PC occurred 
within 3 days from admission – Total costs 
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Appendix VII. Comparison of total costs of PC vs UC defining PC exposure when referral to PC occurred 
within 3 days from admission – Average daily costs 
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